The current RELV market cap is 5.17M. The company's latest EPS is USD 1.4395 and P/E is 2.06.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 35.06M | 35.63M | 32.56M | 27.61M | 24.54M |
Operating Income | -560k | 163k | -333k | -1.83M | -1.71M |
Net Income | -444k | 1.33M | -440k | -1.96M | 2.51M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 15.31M | 19.74M | 16.19M | 13.61M | 14.28M |
Total Liabilities | 4.21M | 7.26M | 6.82M | 6.32M | 4.4M |
Total Equity | 11.1M | 12.48M | 9.37M | 7.29M | 9.88M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -943k | 1.12M | -750k | -1.77M | -1.23M |
Investing | 64k | 96k | 914k | 97k | 8.15M |
Financing | 500k | 4.09M | -2.78M | -135k | -3.72M |
Market Cap | 5.17M |
Price to Earnings Ratio | 2.06 |
Price to Sales Ratio | 0.21 |
Price to Cash Ratio | 0.91 |
Price to Book Ratio | 0.52 |
Dividend Yield | - |
Shares Outstanding | 1.75M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 300 |
52 Week Change | -26.00% |
52 Week High | 7.15 |
52 Week Low | 1.58 |
Spread (Intraday) | 0.27 (8.41%) |
Company Name | Reliv International Inc (PK) |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.reliv.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions